European Primary Care Cardiovascular Society

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

Things to consider when aiming to prevent stroke in a patient with AF

May 25, 2017

What can be learned from the latest hypertension trials?

May 26, 2017

Heart failure diagnosis and management varies substantially across European countries

May 25, 2017

How do the latest guideline changes affect management of dyslipidaemia in primary care?

May 26, 2017

Ingredients of effective strategies to stimulate behaviour change

May 25, 2017

The evidence base for health behaviour changes

Dec. 9, 2015 - EPCCS 2015 - Prague, Czech Republic

Identifying and treating patients with true hypertension

Feb. 24, 2016 - Prague - EPCCS 2015

What is the evidence base for lipid modification in the guidelines updates?

Feb. 24, 2016 - Prague - EPCCS 2015

Heart failure diagnosis and management

Dec. 9, 2015 - EPCCS 2015 - Prague

​Stroke prevention in atrial fibrillation

Mar. 12, 2014 - Amsterdam - Hobbs, Rutten

The EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document 1

Jan. 7, 2014 - EPCCS 2014, Brussels - Prof. David Fitzmaurice

What's the evidence for BP and lipid targets in diabetes?

Nov. 25, 2014 - EPCCS 2014, Brussels

Debate: should we treat lifetime risk or 10-year risk?

Nov. 25, 2014 - Brussels, Belgium - Prof R. Hobbs, Th. Christiaens, C.Brotons & A. Hoes - EPCCS 2014

Alcohol as a risk factor for hypertension

Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014

Reducing weight and increasing exercise - is it feasible?

Nov. 20, 2014 - Brussels, Belgium - Dr. Ian Campbell - EPCCS 2014

CVD and co-morbidities: What are the priorities? 1

Nov. 20, 2014 - EPCCS Brussels - Dr Geert-Jan Geersingh - EPCCS 2014

Diagnosis and management of acute coronary syndromes

Nov. 18, 2014 - Brusselss, Belgium - Dr. Frans Rutten - EPCCS 2014

New EHRA Practical Guide on the use of NOACs for stroke prevention in AF

Mar. 21, 2018 - news

The European Heart Rhythm Association (EHRA) updated its practical guide on use of non-vitamin K antagonist oral anticoagulants in specific clinical situations and particular patient groups.

Shift of statin eligibility to more subjects at intermediate CV risk with new criteria

Mar. 21, 2018 - Cesena FHY, et al. - Am J Cardiol 2018

Defining statin eligibility based on the predicted CV benefit, rather than the absolute CV risk, shifts statin eligibility to more intermediate CV risk subjects.

Central adiposity is stronger associated with risk of MI than general adiposity

Mar. 21, 2018 - Peters SAE, et al. - J Am Heart Assoc. 2018

In a large, prospective, population-based cohort, the waist-to-hip ratio was more strongly associated with the risk of MI compared with BMI, especially in women.

Safety profile of NOAC for SPAF confirmed in large prospective real-world registry

Mar. 20, 2018 - news

New data of the ongoing GLORIA-AF registry on use of dabigatran in AF show low rates of major bleeding and stroke, and long-term safety data are consistent with other real-world and RCT evidence.

Association of physical activity with less CVD mortality in CHD patients

Mar. 19, 2018 - Moholdt T, et al. - J Am Coll Cardiol 2018

Maintaining or increasing physical activity was associated with substantial reductions in CVD mortality risk, in a large cohort of patients with angina pectoris or myocardial infarction.

Second EPCCS Council Meeting: expanding the impact for European GPs

Mar. 15, 2018 - news
Already at the second Council meeting, we shift gears from making plans to taking action and bringing the support of the European Primary Cardiovascular Care Community to a higher level.

EPCCS Council Already at the second Council meeting, we shift gears from making plans to taking action and bringing the support of the European Primary Cardiovascular Care Community to a higher level.

MACE safely reduced by another PCSK9 inhibitor in long term outcomes trial in high-risk patients

Presented at ACC.18 by Ph. Gabriel Steg (Paris, France)

Mar. 13, 2018 - news

ACC 2018 Treatment with alirocumab on top of high-intensity statins lowered MACE by 15% in patients with recent ACS in the ODYSSEY OUTCOMES trial and was associated with a lower rate of all-cause death.

Rate of AF diagnosis improves by self-applied ECG patch

Presented at ACC.18 by Steven Steinhubl (La Jolla, CA, USA)

Mar. 13, 2018 - news

ACC 2018 In the digital mSToPS trial using patient-generated data, a wearable ECG patch improved the rate of AF diagnosis at 1 year compared to routine care.

In post-MI patients with low LVEF, wearable cardioverter-defibrillator reduces total mortality

Presented at ACC.18 by Jeffrey Olgin (San Francisco, CA, USA)

Mar. 13, 2018 - news

ACC 2018 In post-MI patients with a low LVEF, WCD reduced total mortality in the immediate post-MI period (<90 days), but not sudden cardiac death.

Reduction of major vascular events with IL-1β inhibitor in patients with CKD

Presented at ACC.18 by Paul Ridker (Boston, MA, USA)

Mar. 13, 2018 - news

ACC 2018 Treatment with canakinumab reduced MACE+ in patients with CKD in the CANTOS trial, with a stronger reduction in those who achieved on-treatment hsCRP<2 mg/mL compared to >2 mg/mL.

Complication risk in diabetes can be predicted with new stratification

Mar. 7, 2018 - Ahlqvist E et al. - Lancet Diab Endocrinol 2018

In a data-driven cluster analysis of 6 variables in adult patients with newly diagnosed diabetes, 5 categories of patients were identified with different characteristics and risks of complications.

The obesity paradox challenged by new data with regard to CVD morbidity and longevity

Mar. 6, 2018 - Khan SS, et al. - JAMA Cardiol 2018

Overweight and obese individuals have a significantly increased long-term risk for CVD morbidity, and a similar or shorter total longevity, compared with individuals with a normal BMI.